INOVIO PHARMACEUTICALS INC's ticker is and the CUSIP is 45773HAB8. A total of 4 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,247,864 | -0.1% | 5,690,000 | 0.0% | 0.06% | -4.8% |
Q2 2023 | $5,252,453 | +22.3% | 5,690,000 | 0.0% | 0.06% | +21.6% |
Q1 2023 | $4,294,583 | -15.6% | 5,690,000 | 0.0% | 0.05% | -3.8% |
Q4 2022 | $5,089,946 | +14.4% | 5,690,000 | +15.8% | 0.05% | +10.4% |
Q3 2022 | $4,451,000 | -24.0% | 4,915,000 | -23.4% | 0.05% | -18.6% |
Q2 2022 | $5,858,000 | -3.7% | 6,415,000 | 0.0% | 0.06% | 0.0% |
Q1 2022 | $6,081,000 | -23.1% | 6,415,000 | 0.0% | 0.06% | -20.3% |
Q4 2021 | $7,907,000 | +2.3% | 6,415,000 | +23.6% | 0.07% | +10.4% |
Q3 2021 | $7,733,000 | -15.3% | 5,190,000 | 0.0% | 0.07% | -4.3% |
Q2 2021 | $9,130,000 | -3.4% | 5,190,000 | 0.0% | 0.07% | -12.5% |
Q1 2021 | $9,456,000 | +35.3% | 5,190,000 | +23.9% | 0.08% | +56.9% |
Q4 2020 | $6,989,000 | -22.7% | 4,190,000 | 0.0% | 0.05% | -36.2% |
Q3 2020 | $9,043,000 | -17.3% | 4,190,000 | +91.3% | 0.08% | -27.3% |
Q2 2020 | $10,938,000 | +74.2% | 2,190,000 | -47.7% | 0.11% | +20.9% |
Q1 2020 | $6,279,000 | – | 4,190,000 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AQR Arbitrage LLC | 4,225,000 | $3,897,563 | 0.18% |
WOLVERINE ASSET MANAGEMENT LLC | 5,690,000 | $5,247,864 | 0.06% |
D. E. Shaw & Co., Inc. | 6,500,000 | $6,049,225 | 0.01% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |